Humanigen (HGEN) Stock Forecast, Price Target & Predictions
HGEN Stock Forecast
Humanigen stock forecast is as follows: a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
HGEN Analyst Ratings
According to 2 Wall Street analysts, Humanigen's rating consensus is 'Buy'. The analyst rating breakdown for HGEN stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 12, 2022 | H.C. Wainwright | Buy | Buy | Hold |
| Mar 01, 2022 | Cantor Fitzgerald | Overweight | Overweight | Hold |
Humanigen's last stock rating was published by H.C. Wainwright on May 12, 2022. The company gave HGEN a "Buy" rating, the same as its previous rate.
Humanigen Financial Forecast
Humanigen Revenue Forecast
| Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Oct 13 | Jul 13 | Mar 13 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | $221.00K | $221.00K | - | - | $1.04M | $1.04M | - | - | $486.00K | - | - | $20.00K |
| Avg Forecast | $552.50K | $497.25K | $1.18M | $367.17K | $36.66M | $1.34M | $100.00K | $392.70K | $39.21M | $1.21M | $1.35M | $420.00K | $41.94M | $960.00K | $428.16K | $10.13K | $16.73K | $16.36K |
| High Forecast | $663.00K | $596.70K | $1.42M | $440.61K | $44.00M | $1.60M | $120.00K | $471.24K | $47.06M | $1.46M | $1.62M | $504.00K | $50.33M | $1.15M | $513.79K | $12.16K | $20.08K | $19.64K |
| Low Forecast | $442.00K | $397.80K | $945.07K | $293.74K | $29.33M | $1.07M | $80.00K | $314.16K | $31.37M | $971.52K | $1.08M | $336.00K | $33.55M | $768.00K | $342.52K | $8.11K | $13.39K | $13.09K |
| # Analysts | 8 | 7 | 13 | 14 | 18 | 20 | 9 | 19 | 15 | 13 | 9 | 16 | 8 | 8 | 10 | 9 | 20 | 9 |
| Surprise % | - | - | - | - | - | - | 2.21% | 0.56% | - | - | 0.77% | 2.47% | - | - | 1.14% | - | - | 1.22% |
Humanigen's average Quarter revenue forecast for Jul 23 based on 20 analysts is $1.34M, with a low forecast of $1.07M, and a high forecast of $1.60M. HGEN's average Quarter revenue forecast represents a 504.45% increase compared to the company's last Quarter revenue of $221.00K (Mar 23).
Humanigen EBITDA Forecast
| Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Oct 13 | Jul 13 | Mar 13 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 7 | 13 | 14 | 18 | 20 | 9 | 19 | 15 | 13 | 9 | 16 | 8 | 8 | 10 | 9 | 20 | 9 |
| EBITDA | - | - | - | - | - | - | $-4.16M | $4.51M | - | - | $-20.54M | $-37.32M | - | - | $-65.55M | - | - | $-8.53M |
| Avg Forecast | $-110.50K | $-99.45K | $-23.43M | $-38.65M | $4.65M | $-59.34M | $-25.05M | $-41.34M | $4.97M | $-53.94M | $-26.80M | $-44.21M | $5.32M | $-42.64M | $-56.69M | $-11.09M | $-9.47M | $-6.63M |
| High Forecast | $-132.60K | $-119.34K | $-18.74M | $-30.92M | $5.58M | $-47.47M | $-20.04M | $-33.07M | $5.97M | $-43.16M | $-21.44M | $-35.37M | $6.38M | $-34.11M | $-45.35M | $-8.87M | $-7.58M | $-5.31M |
| Low Forecast | $-88.40K | $-79.56K | $-28.11M | $-46.38M | $3.72M | $-71.21M | $-30.07M | $-49.60M | $3.98M | $-64.73M | $-32.16M | $-53.05M | $4.25M | $-51.17M | $-68.03M | $-13.31M | $-11.37M | $-7.96M |
| Surprise % | - | - | - | - | - | - | 0.17% | -0.11% | - | - | 0.77% | 0.84% | - | - | 1.16% | - | - | 1.29% |
9 analysts predict HGEN's average Quarter EBITDA for Mar 23 to be $-25.05M, with a high of $-20.04M and a low of $-30.07M. This is -655.78% lower than Humanigen's previous annual EBITDA (Dec 22) of $4.51M.
Humanigen Net Income Forecast
| Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Oct 13 | Jul 13 | Mar 13 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 7 | 13 | 14 | 18 | 20 | 9 | 19 | 15 | 13 | 9 | 16 | 8 | 8 | 10 | 9 | 20 | 9 |
| Net Income | - | - | - | - | - | - | $-4.15M | $4.39M | - | - | $-21.29M | $-38.52M | - | - | $-65.57M | - | - | $-8.57M |
| Avg Forecast | $183.55M | $159.88M | $-24.26M | $-34.73M | $-0.04 | $-59.97M | $-25.95M | $-37.15M | $-0.21 | $-54.52M | $-27.75M | $-39.73M | $-0.92 | $-43.10M | $-56.71M | $-11.48M | $-9.51M | $-6.67M |
| High Forecast | $231.28M | $201.44M | $-19.41M | $-27.79M | $-0.03 | $-47.98M | $-20.76M | $-29.72M | $-0.16 | $-43.61M | $-22.20M | $-31.79M | $-0.68 | $-34.48M | $-45.37M | $-9.18M | $-7.60M | $-5.33M |
| Low Forecast | $135.83M | $118.31M | $-29.12M | $-41.68M | $-0.05 | $-71.96M | $-31.14M | $-44.58M | $-0.26 | $-65.42M | $-33.30M | $-47.68M | $-1.16 | $-51.72M | $-68.05M | $-13.77M | $-11.41M | $-8.00M |
| Surprise % | - | - | - | - | - | - | 0.16% | -0.12% | - | - | 0.77% | 0.97% | - | - | 1.16% | - | - | 1.29% |
Humanigen's average Quarter net income forecast for Mar 23 is $-25.95M, with a range of $-31.14M to $-20.76M. HGEN's average Quarter net income forecast represents a -691.11% decrease compared to the company's last Quarter net income of $4.39M (Dec 22).
Humanigen SG&A Forecast
| Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Oct 13 | Jul 13 | Mar 13 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 7 | 13 | 14 | 18 | 20 | 9 | 19 | 15 | 13 | 9 | 16 | 8 | 8 | 10 | 9 | 20 | 9 |
| SG&A | - | - | - | - | - | - | $3.72M | $3.30M | - | - | $4.34M | $4.02M | - | - | $4.95M | - | - | $2.02M |
| Avg Forecast | - | - | $4.95M | $4.17M | $4.65M | $6.84M | $5.30M | $4.46M | $4.97M | $6.22M | $5.67M | $4.77M | $5.32M | $4.92M | $4.28M | $2.12M | $1.56M | $1.57M |
| High Forecast | - | - | $5.95M | $5.00M | $5.58M | $8.21M | $6.36M | $5.35M | $5.97M | $7.46M | $6.80M | $5.72M | $6.38M | $5.90M | $5.14M | $2.55M | $1.87M | $1.88M |
| Low Forecast | - | - | $3.96M | $3.33M | $3.72M | $5.47M | $4.24M | $3.57M | $3.98M | $4.97M | $4.53M | $3.81M | $4.25M | $3.93M | $3.42M | $1.70M | $1.25M | $1.26M |
| Surprise % | - | - | - | - | - | - | 0.70% | 0.74% | - | - | 0.77% | 0.84% | - | - | 1.16% | - | - | 1.29% |
Humanigen's average Quarter SG&A projection for Jul 23 is $6.84M, based on 20 Wall Street analysts, with a range of $5.47M to $8.21M. The forecast indicates a 83.93% rise compared to HGEN last annual SG&A of $3.72M (Mar 23).
Humanigen EPS Forecast
| Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Oct 13 | Jul 13 | Mar 13 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 7 | 13 | 14 | 18 | 20 | 9 | 19 | 15 | 13 | 9 | 16 | 8 | 8 | 10 | 9 | 20 | 9 |
| EPS | - | - | - | - | - | - | $-0.03 | $-0.79 | - | - | $-0.32 | $-0.65 | - | - | $-1.25 | - | - | $-22.00 |
| Avg Forecast | $1.54 | $1.34 | $1.58 | $2.09 | $-49.44M | $-0.04 | $0.06 | $1.95 | $-52.88M | $-0.34 | $-0.49 | $1.89 | $-56.55M | $-0.46 | $-0.64 | $19.07 | $-2.64 | $18.00 |
| High Forecast | $1.94 | $1.69 | $1.99 | $2.63 | $-59.33M | $-0.05 | $0.08 | $2.46 | $-63.45M | $-0.43 | $-0.62 | $2.38 | $-67.86M | $-0.58 | $-0.81 | $24.03 | $-2.11 | $22.68 |
| Low Forecast | $1.14 | $0.99 | $1.17 | $1.55 | $-39.55M | $-0.03 | $0.04 | $1.45 | $-42.30M | $-0.25 | $-0.36 | $1.40 | $-45.24M | $-0.34 | $-0.47 | $14.11 | $-3.17 | $13.32 |
| Surprise % | - | - | - | - | - | - | -0.58% | -0.40% | - | - | 0.65% | -0.34% | - | - | 1.95% | - | - | -1.22% |
According to undefined Wall Street analysts, Humanigen's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to HGEN previous annual EPS of $NaN (undefined).